Accelerator Mass Spectrometry (AMS)

Pharmaron is the recognized world leader in the use of Accelerator Mass Spectrometry (AMS) technology for pharmaceutical, animal healthcare and agrochemical applications. Pharmaron acquired Maryland-based Xceleron in 2017 and has now expanded the site to include advanced bioanalytical sciences. Our team is primarily focused on pharmaceutical research and development employing Accelerator Mass Spectrometry (AMS) as a unique, ultra-sensitive ¹⁴C analytical tool to support both clinical and non-clinical investigations.

¹⁴C Radiolabelled Microtracers Ultra-sensitive Analytical Methodology Accelerated Clinical Development Microdosing Phase 0 Clinical PK with Absolute Bioavailability Mass Balance Using AMS Metabolite Profiling Using AMS Non-clinical Studies Using Radiolabelled Compounds ¹⁴C Radiolabels and AMS for Biologics